Article
Genetic engineering of primary human mesenchymal stromal cells using the CRISPR/Cas9 synergistic activation mediator
2025-05-12
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Genomic editing technologies provide rich opportunities to approach inherited human diseases, but gene delivery strategies are still challenging. While engineered induced pluripotent stem cells or adeno-associated viral vectors may be associated with severe adverse effects, mesenchymal stromal cells (MSC) have abundantly been used for various cell therapeutic st...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e4e8e234-2489-5c4a-92e7-d6f58bb9e662
- DOI
- 10.21203/rs.3.rs-6470951/v1
